title: Concurrent chemoradiotherapy for localized nasal natural killer/T-cell lymphoma: an updated analysis of the Japan clinical oncology group study JCOG0211.
authors.forename: Motoko
authors.initials: M
authors.lastname: Yamaguchi
authors.forename: Kensei
authors.initials: K
authors.lastname: Tobinai
authors.forename: Masahiko
authors.initials: M
authors.lastname: Oguchi
authors.forename: Naoki
authors.initials: N
authors.lastname: Ishizuka
authors.forename: Yukio
authors.initials: Y
authors.lastname: Kobayashi
authors.forename: Yasushi
authors.initials: Y
authors.lastname: Isobe
authors.forename: Kenichi
authors.initials: K
authors.lastname: Ishizawa
authors.forename: Nobuo
authors.initials: N
authors.lastname: Maseki
authors.forename: Kuniaki
authors.initials: K
authors.lastname: Itoh
authors.forename: Noriko
authors.initials: N
authors.lastname: Usui
authors.forename: Izumi
authors.initials: I
authors.lastname: Wasada
authors.forename: Tomohiro
authors.initials: T
authors.lastname: Kinoshita
authors.forename: Tomomitsu
authors.initials: T
authors.lastname: Hotta
authors.forename: Kunihiro
authors.initials: K
authors.lastname: Tsukasaki
authors.forename: Kazuo
authors.initials: K
authors.lastname: Oshimi
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols; D005260:Female; D006801:Humans; D054391:Lymphoma, Extranodal NK-T-Cell / Q000188:drug therapy* / Q000532:radiotherapy*; D008297:Male; D009669:Nose Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy*